Alto Neuroscience (ANRO) Research & Development (2023 - 2026)

Alto Neuroscience has disclosed Research & Development across 4 years of filings, most recently posting $20.3 million for Q1 2026.

• Research & Development for Q1 2026 came in at $20.3 million, up 103.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.9 million (up 18.97% YoY), and the FY2025 annual result was $45.6 million, down 2.93% from the prior year.
• Research & Development came in at $20.3 million for Q1 2026 at Alto Neuroscience, up from $12.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $20.3 million in Q1 2026 to a low of -$20.4 million in Q4 2023.
• The 4-year median for Research & Development is $10.5 million (2025), against an average of $8.7 million.
• Across the five-year window, Research & Development surged 152.82% in 2024 and decreased 19.41% in 2025, its largest moves.
• Alto Neuroscience's Research & Development stood at -$20.4 million in 2023, then soared by 152.82% to $10.8 million in 2024, then climbed by 11.07% to $12.0 million in 2025, then soared by 69.17% to $20.3 million in 2026.
• The last three Research & Development figures came in at $20.3 million (Q1 2026), $12.0 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.